Compare StocksMRNA vs MSFT

Moderna, Inc. (MRNA) vs Microsoft Corporation (MSFT)

MRNA
Moderna, Inc.
$52.37
VS
MSFT
Microsoft Corporation
$389.02

Rewards

MRNA
    MSFT
    • Microsoft Corporation has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
    • Gross margin of 68.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
    • Microsoft Corporation scores 88/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.

    Risks

    MRNA
    • ROIC has declined by 61.0 percentage points over the observed period, which may signal competitive erosion.
    • Gross margin of -105.8% is low, suggesting a competitive or commodity-like market with limited pricing power.
    • Moderna, Inc. scores only 17/100 on the Economic Moat Score, suggesting limited durable competitive advantages.
    MSFT
    • FCF yield of 2.5% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.

    Key Valuation Metrics

    Learn more →
    MRNA
    MSFT
    Valuation
    $-1.33B
    Free Cash Flow
    $71.61B
    -6.41%
    FCF Yield
    2.48%
    N/A
    Trailing P/E
    24.33
    -11.51
    Forward P/E
    20.64
    Quality & Moat
    -19.50%
    ROIC
    22.10%
    -32.62%
    ROE
    26.05%
    -105.76%
    Gross Margin
    68.59%
    N/A
    PEG Ratio
    0.41
    Balance Sheet Safety
    0.15
    Debt / Equity
    0.32
    N/A
    Interest Coverage
    N/A
    N/A
    Net Debt / EBITDA
    0.19
    N/A
    Dividend Yield
    0.94%
    MRNA: 2Ties: 1MSFT: 5
    MRNAMSFT

    Historical Fundamentals

    Learn more →
    MRNA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

    MSFT

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

    $1 Retained Earnings Test

    Learn more →
    MRNA
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-11.10B
    Δ Market Cap
    $-57.53B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    MSFT
    $9.18
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $196.68B
    Δ Market Cap
    +$1.81T
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    MRNA
    Insufficient Data
    Enter initial FCF to calculate intrinsic value
    Current Price: $52.37
    Fair Value: $0.00
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    MSFT
    0.5% Overvalued
    Price is 0.5% above estimated fair value
    Current Price: $389.02
    Fair Value: $387.10
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    MRNA

    Requires positive FCF to compute implied growth rate.

    MSFT

    What growth rate is the market pricing in at $389?

    +12.6%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +17.4%

    The market implies +12.6% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +17.4%, reflecting ongoing growth investment.

    Economic Moat Score

    Learn more →
    MRNA
    17/100
    No Moat
    70+ Wide · 40-69 Narrow · <40 None

    No durable competitive advantage detected. The business shows limited evidence of pricing power, consistent returns, or capital efficiency.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
    MSFT
    88/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    MRNA
    -3.72
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    MSFT
    -2.51
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    MRNA
    Insiders 7.3%Institutions 77.1%Retail & Other 15.5%
    No. of Institutional Holders978
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    MSFT
    Insiders 0.1%Institutions 76.0%Retail & Other 23.9%
    No. of Institutional Holders8,054
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    MRNA
    0
    Buys (3M)
    0
    Buys (12M)
    SAGAN PAUL L
    Director
    $1.00M
    @ $31.76 · 2025-03-03
    BANCEL STEPHANE J
    Chief Executive Officer
    $5.00M
    @ $31.22 · 2025-03-03
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    MSFT
    1
    Buys (3M)
    2
    Buys (12M)
    Total value (12M): $3.44M
    STANTON JOHN W.
    Director
    $1.99M
    @ $397.35 · 2026-02-18
    SMITH BRADFORD LEE
    President
    $1.45M
    @ $377.47 · 2025-04-23
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    MRNA
    2
    Sells (3M)
    4
    Sells (12M)
    Total value (12M): $8.56M
    KLINGER SHANNON THYME
    Officer
    $726,047
    @ $52.29 · 2026-03-02
    HOGE STEPHEN
    President
    $7.81M
    @ $48.84 · 2026-02-23
    HUSSAIN SHAH ABBAS
    Director
    $13,910
    @ $27.60 · 2025-12-09
    HUSSAIN SHAH ABBAS
    Director
    $8,736
    @ $28.00 · 2025-06-11
    KLINGER SHANNON THYME
    Officer
    $23,637
    @ $44.68 · 2024-12-09
    HOGE STEPHEN
    President
    $13,595
    @ $43.30 · 2024-12-03
    KLINGER SHANNON THYME
    Officer
    $4,849
    @ $43.29 · 2024-12-03
    HOGE STEPHEN
    President
    $12,452
    @ $42.79 · 2024-11-29
    MOCK JAMES M
    Chief Financial Officer
    $60,761
    @ $42.79 · 2024-11-29
    KLINGER SHANNON THYME
    Officer
    $60,675
    @ $42.79 · 2024-11-29
    HOGE STEPHEN
    President
    $12,771
    @ $46.10 · 2024-11-11
    MOCK JAMES M
    Chief Financial Officer
    $42,986
    @ $60.12 · 2024-10-07
    KLINGER SHANNON THYME
    Officer
    $40,539
    @ $73.57 · 2024-09-09
    HOGE STEPHEN
    President
    $24,483
    @ $76.99 · 2024-09-03
    KLINGER SHANNON THYME
    Officer
    $8,777
    @ $76.99 · 2024-09-03
    HOGE STEPHEN
    President
    $23,408
    @ $78.03 · 2024-08-29
    MOCK JAMES M
    Chief Financial Officer
    $12,640
    @ $78.02 · 2024-08-29
    KLINGER SHANNON THYME
    Officer
    $12,640
    @ $78.02 · 2024-08-29
    MOCK JAMES M
    Chief Financial Officer
    $104,881
    @ $79.40 · 2024-08-28
    KLINGER SHANNON THYME
    Officer
    $104,722
    @ $79.39 · 2024-08-28
    HOGE STEPHEN
    President
    $21,363
    @ $84.11 · 2024-08-12
    AFEYAN NOUBAR BOGHOS
    Director
    $1.80M
    @ $119.96 · 2024-07-31
    AFEYAN NOUBAR BOGHOS
    Director
    $1.77M
    @ $117.80 · 2024-07-24
    AFEYAN NOUBAR BOGHOS
    Director
    $1.84M
    @ $122.84 · 2024-07-17
    HOGE STEPHEN
    President
    $1.82M
    @ $121.12 · 2024-07-15
    AFEYAN NOUBAR BOGHOS
    Director
    $1.76M
    @ $117.08 · 2024-07-10
    MOCK JAMES M
    Chief Financial Officer
    $81,465
    @ $118.24 · 2024-07-08
    AFEYAN NOUBAR BOGHOS
    Director
    $1.91M
    @ $127.22 · 2024-06-26
    AFEYAN NOUBAR BOGHOS
    Director
    $2.00M
    @ $133.57 · 2024-06-18
    HOGE STEPHEN
    President
    $2.07M
    @ $138.16 · 2024-06-17
    AFEYAN NOUBAR BOGHOS
    Director
    $2.21M
    @ $147.20 · 2024-06-12
    KLINGER SHANNON THYME
    Officer
    $766,785
    @ $148.09 · 2024-06-10
    AFEYAN NOUBAR BOGHOS
    Director
    $2.27M
    @ $151.25 · 2024-06-05
    HOGE STEPHEN
    President
    $47,704
    @ $140.72 · 2024-06-03
    MOCK JAMES M
    Chief Financial Officer
    $97,237
    @ $140.72 · 2024-06-03
    KLINGER SHANNON THYME
    Officer
    $17,168
    @ $140.72 · 2024-06-03
    AFEYAN NOUBAR BOGHOS
    Director
    $2.90M
    @ $145.08 · 2024-05-29
    HOGE STEPHEN
    President
    $49,276
    @ $144.50 · 2024-05-29
    MOCK JAMES M
    Chief Financial Officer
    $26,444
    @ $144.50 · 2024-05-29
    KLINGER SHANNON THYME
    Officer
    $26,444
    @ $144.50 · 2024-05-29
    MOCK JAMES M
    Chief Financial Officer
    $105,283
    @ $162.47 · 2024-05-28
    KLINGER SHANNON THYME
    Officer
    $210,566
    @ $162.47 · 2024-05-28
    AFEYAN NOUBAR BOGHOS
    Director
    $2.36M
    @ $157.57 · 2024-05-22
    AFEYAN NOUBAR BOGHOS
    Director
    $1.91M
    @ $127.32 · 2024-05-15
    HOGE STEPHEN
    President
    $1.91M
    @ $127.49 · 2024-05-15
    HOGE STEPHEN
    President
    $30,844
    @ $120.96 · 2024-05-10
    AFEYAN NOUBAR BOGHOS
    Director
    $1.83M
    @ $121.68 · 2024-05-08
    AFEYAN NOUBAR BOGHOS
    Director
    $1.66M
    @ $110.92 · 2024-05-01
    AFEYAN NOUBAR BOGHOS
    Director
    $1.62M
    @ $108.32 · 2024-04-24
    AFEYAN NOUBAR BOGHOS
    Director
    $1.55M
    @ $103.38 · 2024-04-17
    HOGE STEPHEN
    President
    $1.58M
    @ $105.02 · 2024-04-15
    AFEYAN NOUBAR BOGHOS
    Director
    $1.61M
    @ $107.12 · 2024-04-10
    MOCK JAMES M
    Chief Financial Officer
    $71,859
    @ $101.93 · 2024-04-08
    AFEYAN NOUBAR BOGHOS
    Director
    $1.53M
    @ $101.68 · 2024-04-03
    AFEYAN NOUBAR BOGHOS
    Director
    $1.64M
    @ $109.06 · 2024-03-27
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    MSFT
    1
    Sells (3M)
    13
    Sells (12M)
    Total value (12M): $172.43M
    HOGAN KATHLEEN T
    Officer
    $5.05M
    @ $409.55 · 2026-03-06
    NUMOTO TAKESHI
    Officer
    $1.36M
    @ $478.72 · 2025-12-04
    ALTHOFF JUDSON
    Officer
    $6.27M
    @ $491.52 · 2025-12-02
    SMITH BRADFORD LEE
    President
    $19.97M
    @ $518.64 · 2025-11-03
    NADELLA SATYA
    Chief Executive Officer
    $75.32M
    @ $504.78 · 2025-09-03
    NUMOTO TAKESHI
    Officer
    $2.56M
    @ $527.32 · 2025-08-12
    NUMOTO TAKESHI
    Officer
    $1.39M
    @ $463.00 · 2025-06-03
    NUMOTO TAKESHI
    Officer
    $460,008
    @ $460.01 · 2025-05-30
    HOGAN KATHLEEN T
    Officer
    $9.76M
    @ $453.77 · 2025-05-21
    ALTHOFF JUDSON
    Officer
    $7.33M
    @ $458.18 · 2025-05-19
    COLEMAN AMY
    Officer
    $5.99M
    @ $452.04 · 2025-05-15
    SMITH BRADFORD LEE
    President
    $1.68M
    @ $438.44 · 2025-05-05
    SMITH BRADFORD LEE
    President
    $35.30M
    @ $435.84 · 2025-05-05
    NUMOTO TAKESHI
    Officer
    $1.12M
    @ $447.41 · 2024-12-09
    NUMOTO TAKESHI
    Officer
    $874,634
    @ $437.32 · 2024-12-04
    NUMOTO TAKESHI
    Officer
    $1.50M
    @ $428.76 · 2024-12-02
    ALTHOFF JUDSON
    Officer
    $10.43M
    @ $417.00 · 2024-11-22
    NUMOTO TAKESHI
    Officer
    $414,720
    @ $414.72 · 2024-11-22
    YOUNG CHRISTOPHER DAVID
    Officer
    $3.05M
    @ $423.66 · 2024-11-12
    HOGAN KATHLEEN T
    Officer
    $7.16M
    @ $411.86 · 2024-09-10
    NUMOTO TAKESHI
    Officer
    $1.03M
    @ $411.04 · 2024-09-10
    SMITH BRADFORD LEE
    President
    $16.10M
    @ $402.59 · 2024-09-09
    HOOD AMY E
    Chief Financial Officer
    $15.60M
    @ $410.55 · 2024-09-05
    NADELLA SATYA
    Chief Executive Officer
    $32.02M
    @ $408.63 · 2024-09-04
    NUMOTO TAKESHI
    Officer
    $235,535
    @ $416.14 · 2024-06-03
    ALTHOFF JUDSON
    Officer
    $10.64M
    @ $425.68 · 2024-05-23
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    MRNA
    FearGreed
    😐Neutral(47/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    MSFT
    FearGreed
    😐Neutral(43/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    MRNA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (47)
    MSFT
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (43)
    View MRNA Full AnalysisView MSFT Full Analysis